Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

Efficacy and safety of gefapixant, a P2X₃ receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.

McGarvey, Lorcan P; Birring, Surinder S; Morice, Alyn H; Dicpinigaitis, Peter V; Pavord, Ian D; Schelfhout, Jonathan; Nguyen, Allison Martin; Li, Qing; Tzontcheva, Anjela; Iskold, Beata; Green, Stuart A; Rosa, Carmen La; Muccino, David R; Smith, Jaclyn A.

Lancet ; 399(10328): 909-923, 2022 03 05.

Artículo en Inglés | MEDLINE | ID: mdl-35248186

2.

Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.

Dicpinigaitis, Peter V; Birring, Surinder S; Blaiss, Michael; McGarvey, Lorcan P; Morice, Alyn H; Pavord, Ian D; Satia, Imran; Smith, Jaclyn A; La Rosa, Carmen; Li, Qing; Nguyen, Allison Martin; Schelfhout, Jonathan; Tzontcheva, Anjela; Muccino, David.

Ann Allergy Asthma Immunol ; 130(1): 60-66, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-35569802

3.

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.

Dicpinigaitis, Peter V; Morice, Alyn H; Smith, Jaclyn A; Sher, Mandel R; Vaezi, Michael; Guilleminault, Laurent; Niimi, Akio; Gude, Kerstin; Krahn, Ulrike; Saarinen, Riitta; Pires, Philippe Vieira; Wosnitza, Melanie; McGarvey, Lorcan.

Lung ; 201(3): 255-266, 2023 06.

Artículo en Inglés | MEDLINE | ID: mdl-37261531

4.

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough.

McGarvey, Lorcan; Smith, Jaclyn A; Morice, Alyn; Birring, Surinder S; Chung, Kian Fan; Dicpinigaitis, Peter V; Niimi, Akio; Benninger, Michael S; Sher, Mandel; Matsunaga, Yuko; Miyazaki, Sayaka; Machida, Mitsuaki; Ishihara, Hiroyuki; Mahmood, Adnan; Gomez, Juan-Carlos.

Lung ; 201(1): 25-35, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36512069

5.

Evidence for Alpha₇ Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.

Canning, Brendan J; Liu, Qi; Tao, Mayuko; DeVita, Robert; Perelman, Michael; Hay, Douglas W; Dicpinigaitis, Peter V; Liang, Jing.

J Pharmacol Exp Ther ; 380(2): 94-103, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-34782407

6.

Long-Term Follow up of Renal and Other Acute Organ Failure in Survivors of Critical Illness Due to Covid-19.

Chand, Sudham; Kapoor, Sumit; Naqvi, Ali; Thakkar, Jyotsana; Fazzari, Melissa J; Orsi, Deborah; Dieiev, Vladyslav; Lewandowski, David C; Dicpinigaitis, Peter V.

J Intensive Care Med ; 37(6): 736-742, 2022 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-34918990

7.

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.

Smith, Jaclyn A; Birring, Surinder S; Dicpinigaitis, Peter V; McGarvey, Lorcan P; Morice, Alyn H; Pavord, Ian D; Satia, Imran; Green, Stuart; Iskold, Beata; La Rosa, Carmen; Li, Qing; Martin Nguyen, Allison; Schelfhout, Jonathan; Muccino, David.

Lung ; 200(4): 423-429, 2022 08.

Artículo en Inglés | MEDLINE | ID: mdl-35895098

8.

COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.

Chand, Sudham; Kapoor, Sumit; Orsi, Deborah; Fazzari, Melissa J; Tanner, Tristan G; Umeh, Genevieve C; Islam, Marjan; Dicpinigaitis, Peter V.

J Intensive Care Med ; 35(10): 963-970, 2020 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-32812834

9.

P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough.

Dicpinigaitis, Peter V; McGarvey, Lorcan P; Canning, Brendan J.

Lung ; 198(4): 609-616, 2020 08.

Artículo en Inglés | MEDLINE | ID: mdl-32661659

10.

Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia.

Dicpinigaitis, Peter V; Trachuk, Polina; Fakier, Feizal; Teka, Mestawet; Suhrland, Mark J.

Lung ; 198(1): 31-33, 2020 02.

Artículo en Inglés | MEDLINE | ID: mdl-31583455

11.

Diabetes Insipidus After Discontinuation of Vasopressin Infusion for Treatment of Shock.

Ferenchick, Hannah; Cemalovic, Nail; Ferguson, Nadia; Dicpinigaitis, Peter V.

Crit Care Med ; 47(12): e1008-e1013, 2019 12.

Artículo en Inglés | MEDLINE | ID: mdl-31567344

12.

Prevalence of Arnold nerve reflex in subjects with and without chronic cough: Relevance to Cough Hypersensitivity Syndrome.

Dicpinigaitis, Peter V; Enilari, Oladunni; Cleven, Krystal L.

Pulm Pharmacol Ther ; 54: 22-24, 2019 02.

Artículo en Inglés | MEDLINE | ID: mdl-30445192

13.

Antitussive therapy: A role for levodropropizine.

Birring, Surinder; de Blasio, Francesco; Dicpinigaitis, Peter V; Fontana, Giovanni; Lanata, Luigi; Page, Clive; Saibene, Federico; Zanasi, Alessandro.

Pulm Pharmacol Ther ; 56: 79-85, 2019 06.

Artículo en Inglés | MEDLINE | ID: mdl-30872161

14.

LUNG Year in Review: 2023.

Dicpinigaitis, Peter V.

Lung ; 202(1): 1-4, 2024 02.

Artículo en Inglés | MEDLINE | ID: mdl-38305892

15.

Reply to Weinberger.

Birring, Surinder S; Morice, Alyn H; Dicpinigaitis, Peter V; McGarvey, Lorcan P; Pavord, Ian D; Green, Stuart A; Philip, George; Smith, Jaclyn A.

Am J Respir Crit Care Med ; 207(12): 1650-1651, 2023 Jun 15.

Artículo en Inglés | MEDLINE | ID: mdl-37104844

16.

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.

Birring, Surinder S; Dicpinigaitis, Peter V; Smith, Jaclyn A; Morice, Alyn H; McGarvey, Lorcan P; Pavord, Ian D; Nguyen, Allison Martin; Schelfhout, Jonathan; Li, Qing; Iskold, Beata; Green, Stuart A; Philip, George; Muccino, David R; La Rosa, Carmen.

Am J Respir Crit Care Med ; 207(11): 1539-1542, 2023 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-36996347

17.

LUNG Year in Review: 2022.

Dicpinigaitis, Peter V.

Lung ; 201(1): 1-4, 2023 02.

Artículo en Inglés | MEDLINE | ID: mdl-36717405

18.

Effect of tobacco and electronic cigarette use on cough reflex sensitivity.

Dicpinigaitis, Peter V.

Pulm Pharmacol Ther ; 47: 45-48, 2017 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-28185897

19.

LUNG Year in Review: 2021.

Dicpinigaitis, Peter V.

Lung ; 200(1): 1-4, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-35041063

20.

Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done.

Chung, Kian Fan; Birring, Surinder S; Morice, Alyn H; McGarvey, Lorcan P; Mazzone, Stuart B; Maher, Toby M; Dicpinigaitis, Peter V.

Lung ; 200(6): 673-675, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36348052

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Efficacy and safety of gefapixant, a P2X₃ receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials.

Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough.

Evidence for Alpha₇ Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.

Long-Term Follow up of Renal and Other Acute Organ Failure in Survivors of Critical Illness Due to Covid-19.

Improvements in Objective and Subjective Measures of Chronic Cough with Gefapixant: A Pooled Phase 3 Efficacy Analysis of Predefined Subgroups.

COVID-19-Associated Critical Illness-Report of the First 300 Patients Admitted to Intensive Care Units at a New York City Medical Center.

P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough.

Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia.

Diabetes Insipidus After Discontinuation of Vasopressin Infusion for Treatment of Shock.

Prevalence of Arnold nerve reflex in subjects with and without chronic cough: Relevance to Cough Hypersensitivity Syndrome.

Antitussive therapy: A role for levodropropizine.

LUNG Year in Review: 2023.

Reply to Weinberger.

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks.

LUNG Year in Review: 2022.

Effect of tobacco and electronic cigarette use on cough reflex sensitivity.

LUNG Year in Review: 2021.

Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done.